Gunilla is Professor of oncology at Uppsala University since 2013 and chief physician at Uppsala University Hospital. Her research areas include clinical and tumor biological studies of malignant lymphomas, as well as immunotherapy including clinical studies of CAR T cells. Since 2019, she is chairman of the Swedish CAR T-cell group and is also a scientific advisor to XNK-therapeutics and Elicera Therapeutics. She is a member of the board of the Cancer Foundation and the Department of Immunology, Genetics and Pathology at Uppsala University. Since 2017, she is also a member of the Royal Swedish Society of Science in Uppsala.